A key F.D.A. advisory panel recommended the use of the Pfizer vaccine in 5- to 11-year-olds, who could start getting shots late next week.

Letter From Australia: A Never-Ending Pandemic?

(J. Harris: This is an excellent, readable, short letter regarding the Australian Covid experience.)

China locks down a northwestern city to subdue a small outbreak.


GREETING S FROM THE FURHER BUNKER COMPLETE WITH GUARD DOG. We had a bit of wind this morning, but the bunker is warm and dry and the tornado went around us. 



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE







A Covid update (J. Harris: Excellent. Current.)


(J. Harris: “Small town hospitals, not necessarily ‘Rural’ often are not busy enough to remain open.”

Long-term consequences of the misuse of ivermectin data

”…On March 31, 2021, WHO advised that ivermectin should only be used within clinical trials and not as part of routine clinical practice.4 This advice was followed by the manufacturer, Merck, that stated on Feb 4, 2021, that there is “no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease”.5 Despite this, ivermectin is being routinely used in some Latin American settings amid recommendations from some governments and health professionals….Sustained misinformation can lead to diversion of limited health-care and government resources to addressing rumours rather than making genuine public heath progress. Proactive health promotion and education is needed right now to ensure that locally trusted actors and communicators (including, but not limited to, health-care workers) are aware of the uncertainty around the ivermectin evidence base for managing COVID-19, and that it remains a vital medicine for managing neglected tropical disease. Where advocacy emerged from official or high-level sources during the COVID-19 pandemic, we have concerns that the likelihood of mistrust within communities will increase. International and national global health policy stakeholders must be made aware that this mistrust could be an issue that needs addressing in both the short-term and medium-term future….”

If You’re Unvaccinated for Covid Can Your Doctor Refuse to Treat You?



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE



1. What Amazon’s chief health officer says is the biggest workplace health challenge of the century

2. COVID-19 reinfection likely for unvaccinated, study suggests

”…”Reinfection can reasonably happen in three months or less… “Therefore, those who have been naturally infected should get vaccinated. Previous infection alone can offer very little long-term protection against subsequent infections…Researchers also predicted reinfection will become “increasingly common” as COVID-19 transitions into an endemic disease. 


Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America

(J. Harris: A comprehensive review of the state of medical care in the US with suggestions for needed improvements. Readable.)

”…Covid-19 also made us walk backward and see the larger worldview, in the process revealing uncomfortable truths about the U.S. health care system — including our approach to managing chronic diseases…”

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity

(J. Harris: A very readable summary of Covid related antibodies and questions. I edited it a little. A few readers are interested in this area of study.)

”…“Individuals can have neutralizing antibodies and still get infected,…. “We know that higher antibody levels, specifically higher neutralizing antibody levels, are better. But we don’t know how high is high enough….So far, only one commercially available SARS-CoV-2 antibody test, from Ortho-Clinical Diagnostics, has been calibrated to the World Health Organization’s reference standard… the test sold through Epitome Risk Solutions’ subsidiary, FourthWall Testing, appeared to be an at-home version of the FDA-authorized GenScript cPass SARS-CoV-2 Neutralization Antibody Detection Kit, a surrogate assay that indirectly measures neutralizing antibodies. According to an FDA spokesperson, the cPass test does not have authorization for sample collection at home. And despite Epitome’s marketing hype, GenScript states that customers “should not interpret the results of this test as an indication or degree of immunity or protection from reinfection….[Actually],The immunological component that is associated with protection against severe disease is immunological memory B cells,.. “These cells aren’t making antibodies, but they remember that they have seen this SARS-CoV-2 spike protein before….circulating antibodies against the virus peak 2 or 3 months after natural infection or vaccination and then begin to decrease. But the immune system’s ability to mount a defense lasts longer. “Just because we’re seeing a decrease in antibody levels doesn’t necessarily mean that your immunity is gone,…We know from a lot of studies now that your memory T cells and memory B cells persist for at least 6 to 8 months and continue to evolve and mature, and none of that information is relayed by an antibody test….that reinfection with the virus activates memory B cells to differentiate into antibody-secreting cells. Because this process can take 3 to 5 days, it doesn’t stop SARS-CoV-2 infections from occurring, but it does help tamp down severe COVID-19. And that’s a success story….“The goal of the vaccine is to protect you against serious illness….Managing expectations for COVID-19 vaccines may be in order. “I think there was maybe an initial misunderstanding amongst the public that this would just halt all infections, and that’s just not the case,…     Ultimately…advice for avoiding a SARS-CoV-2 infection in the first place comes down to a now-familiar combination of measures: “getting vaccinated, frequently washing your hands, wearing a mask, and avoiding high congregate in-door settings, particularly in areas that have high case rates….”



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE



(J. Harris: Note that East Texas Covid has “burned out” for now.)


(J. Harris: Good HOPKINS summary of recent Covid Vaccine decisions)


BOOSTER DOSES The US FDA’s Vaccines and Related Biological Products Advisory Committee during 2 days of meetings last week considered several questions related to booster doses for SARS-CoV-2 vaccines. The panel’s recommendations are not binding, although the FDA generally follows the advice of its committees. ModernaThe vaccine advisory panel on October 14 voted unanimously to endorse a booster dose of Moderna’s SARS-CoV-2 vaccine, administered at least 6 months after the second dose. The vote supports authorizing an additional dose of the vaccine in the same groups authorized for a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine, including individuals aged 65 and older, those ages 18 to 64 at a higher risk for severe disease, and people at risk of exposure due to their occupation. The advisory panel also discussed when booster doses should be provided to all adults but concluded it is too soon to make that decision. The Moderna booster under consideration is 50μg, half the dose of the initial 2 shots, while the authorized booster for the Pfizer-BioNTech vaccine is the same formulation as the FDA-approved 2-dose vaccine. Moderna claims a half dose is enough to activate the immune system while still stretching the world’s supply of available vaccines. Data from Moderna show that the booster dose did not produce the 4-fold antibody increase set as a guideline by the FDA for authorizing boosters, but Moderna said it was because of existing high levels of antibodies in study participants. Some panel members expressed concern over some of the data provided by Moderna—including on how best to measure correlates of protection and durability provided by a half dose—but not enough to prevent endorsement of booster doses. Others noted that avoiding public confusion over which vaccines were approved for booster doses and why played a role in their decision. J&J-JanssenDuring a second day of meetings on October 15, the vaccine advisory panel voted unanimously to endorse a second dose of the J&J-Janssen SARS-CoV-2 vaccine for all recipients. This meeting saw more controversy than previous meetings on booster shots for the Pfizer-BioNTech and Moderna SARS-CoV-2 vaccines, with some panelists reportedly unhappy with multiple slides presented by J&J-Janssen that contained data not previously vetted by the FDA. Additionally, the companies presented data on boosters given at 6 months from a study with a sample size of only 17 volunteers. Panelists expressed frustration with and hesitancy to make a decision based on the limited data, but all the panelists agreed that anyone who received the J&J-Janssen vaccine should be eligible for a second dose, with some saying the vaccine should be considered as a 2-dose regimen. The concerns revolved around data showing that a single dose of J&J-Janssen offered lower protection than 2 doses of either the Pfizer-BioNTech or Moderna vaccines.  Mix & MatchFollowing its vote on the J&J-Janssen vaccine, the panel discussed the so-called “mix & match” strategy, which could allow heterologous booster doses for certain populations. Data from an NIH study released last week showed that the antibody levels of those who initially received the J&J-Janssen shot rose 76-fold in 15 days following a booster with Moderna and 35-fold after a booster with Pfizer-BioNTech. By comparison, a second dose of J&J-Janssen only raised antibody levels 4-fold in the same timeframe. It is worth noting that there were concerns because the NIH study results were based on a small number of volunteers and only reported short-term findings. Despite these concerns, some panelists claimed the data are enough to convince them to support a mix & match strategy, something that is fairly common in other countries.  The FDA is expected to authorize boosters for some Moderna and all J&J-Janssen vaccine recipients as early as this week and also could make a decision on the mix & match strategy. The US CDC’s Advisory Committee on Immunization Practices (ACIP) is scheduled to meet this week to make its own recommendations on booster doses, meaning millions more people in the US could be eligible for additional shots by the end of the week.  AND LAST BUT NOT LEASED: 



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE


F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots

Why Public Health Faces a Crisis Across the U.S.

AY.4 Delta sub-lineage now predominant in UK and Australia, rising in the US

Changes in Cigarette Sales in the United States During the COVID-19 Pandemic

”…The finding shows a surge in cigarette sales during the COVID-19 pandemic. We estimated an increase of about 0.34 pack per month per capita, corresponding to about a 14.1% increase above the expected sales. Excess sales of cigarettes reported in this study align with findings from Nielsen retail tobacco sales data of increases in tobacco sales from April to June 2020 (4). However, this study shows that increases in cigarette sales went beyond the first 3 months of the COVID-19 pandemic and persisted in the 16 months after its onset in March 2020…”


”…Colin Powell died at 84 of complications from a coronavirus infection. Powell was vaccinated, though he had several factors for a weakened immune response: He was an elderly man and he had been treated in recent years for multiple myeloma, a blood cancer. This event is no reason to avoid vaccination — in fact, as these charts show, as more people are immunized, the risk of death decreases even among the most vulnerable

(J. Harris: Obviously the general was immunocompromised by his Multiple Myeloma and/or Chemo. RIP to a good man.




Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: Interim Results of a Large-scale, Double-blind, Randomised, Placebo-controlled Phase 2 Trial in Taiwan (Lancet Respiratory Medicine) MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown to be well tolerated with a good safety profile in healthy adults aged 20–49 years in a phase 1 trial, and provided a good cellular and humoral immune responses. We present the interim safety, tolerability, and immunogenicity results of a phase 2 clinical trial of the MVC-COV1901 vaccine in Taiwan.




GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE



Why many Black Americans changed their minds

Association between digital smart device use and myopia: a systematic review and meta-analysis

(J. Harris: Impt. article about near sighted vision. Not related to Covid. )


(J. Harris: Readable and interesting. Sent to me by a Houston area internist.)




GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE

Opinion: More Bad News on Tap for Marshall’s Shaun Kelehan

By George Smith  — October 15, 2021

Shaun Bobbi Kelehan of Marshall has not had a good couple of years.

The former Marshall doctor and former owner of Marshall’s Access Family Health clinic on Alamo Boulevard surrendered his medical license earlier this year rather than having the state Medical Board revoke it foe cause. He was also an owner and a physician at a clinic in Longview; additionally, he is a partner in clinics in Tyler and the Austin area. Access Family Health was an expanding network of boutique health clinics throughout Texas before being sold earlier this year.

In rapid-fire order in the last four years, Kelehan:

*  Was hit with a 2017 criminal investigation by the Marshall Police Department that found evidence of sexual assault and improper use of medication on a patient. Despite video and audio evidence in which he admitted the acts, Kelehan was no-billed on any charges by a Gregg County grand jury (with  special prosecutor after Harrison County Prosecutor Coke Solomon recused himself, citing he was a patient of Kelehan. The audio and video confessions were not played for the grand jury; special prosecutor ——– of Longview said he “jury did not request they be played.”

*  Had his practice of medicine drastically curtailed by the medical board, including an order that stated he could no longer administer medical treatment to male patients; could not prescribe prescription drugs to male patients; doctor’s Physician Assistants (PA) at his clinics could not see male patients; female patients can only be seen at his clinics; and he could not provide telemedicine sessions.

*  Was the main subject of a front-page investigative story in the Austin American-Statesman about patient abuse by Texas doctors.

*  Was informed with the revelation that a second alleged victim to sexual assault had complained, which prompted the medical board to schedule a second disciplinary hearing.

*  Abruptly volunteered to surrender his medical license; the board accepted his resignation without comment.


*  Announced his retirement and that his entire business interests had been sold.

 His troubles did not end there.

 On October 1, Dallas attorney Mark Perrin with The Perrin Law Firm in Dallas filed a civil suit in Harrison County (District 7 Court) alleging Kelehan deliberately over-medicated and sexually abused former Marshall resident Steven Trey Wood.

Wood is seeking monetary damages in “excess of $1 million.” Additionally, the suit requests Wood receive “exemplary damages, costs of suit, prejudgment interest at the maximum rate allowed by law”, plus “other and further relief…to which Plaintiff shows himself entitled.”

A request for comment from Kelehan was emailed but no response was received by deadline.

Wood, a former outstanding Marshall High School athlete, is an admitted alcoholic and drug abuser, spent two years in the Texas penal system for robbing a drug dealer, and has been in detox and rehab facilities numerous times.

The allegations in the lawsuit include:

*  On at least two occasions, according to statements from the alleged victim, and from videotapes of Kelehan, the former doctor “rendered Wood unconscious with the express intent or having sexual relations”.  In one of the alleged attacks, according to the prior testimony, Woods “woke up” to find Kelehan’s penis in his mouth.  (Note: The attacks allegedly occurred at Dr. Kelehan’s residence at 303 Henley Perry Drive and at his guest house, the historic Trammel’s Trace log cabin, which is adjacent to the residence. The cabin, the oldest house in Harrison County, received the first Texas historical building medallion in the county in 1962, and in 1965 received a Texas Historical Marker.)

*  That Kelehan, despite having a personal and professional relationship with Wood, and knowing his dependence on drugs, provided him with narcotics, opiates and benezodiaszepines (anti-anxiety). The lawsuit charges that Kelehan “enabled” and ‘exacerbated” Wood’s addiction.

*  Wood was provided drugs through prescriptions and sometimes “without a prescription”, with some coming from a “container in (Kelehan’s) home that contained medications that had been returned by patients.

*  Kelehan’s providing drugs to Wood “took an even more nefarious turn”, including two occasions the former doctor drugged Wood with Seroquel (sleeping agent), Librium (anti-anxiety and acute alcohol withdrawal) and/or Klonopin” (sleeping agent). The suit emphatically asserts Kelehan administered the  prescription medication without a prescription and  “with full knowledge” of Wood’s drug addiction and what affect the drugs would have on him, (and) that he gave Wood “the drugs for the purpose of incapacitating him.”

*  After giving the drugs to Wood, Kelehan sexually assaulted him in his guest house. In the audio and video recordings Wood obtained following a request by the Marshall police investigator, Kellehan admitted to the sexual encounter, plus another nonconsensual earlier sexual encounter to which  Wood has testified he did not remember.

*  Kelehan “took steps to fraudulently conceal wrongful actions” from Wood.

*  The lawsuit also alleges Kelehan’s former company Access Family Health is also responsible for the abuse charged by Wood as the company “failed to properly supervise or train” Kelehan.

And, there is still more to the story.

A reporter, attempting to get a copy of the filed lawsuit made six calls to the Harrison County Courthouse, including to the office of District Judge Brad Morin, District Clerk Sherry Griffis and District Attorney Reid McCain.

 In succession, the reporter was told: 1. The case was sealed; 2. contact the district attorney; 3. the case could not be located; 4. a deputy clerk would check with the clerk and call back; 5. the deputy called and said the “case being sealed was a mistake” and it was unsealed and ready for viewing. (The reporter had already received an email copy from the Perrin Law Firm.)

The reporter, having covered court cases for more than 40 years asked or stated at each juncture of the find-the-case hunt:

“Who sealed the case?”

“Why was it sealed?”

“The plaintiff’s attorney did not know it was sealed. How could that be?”

“What does the district attorney have to do with a civil case?”

“How can a case be accidentally sealed? Doesn’t a judge have to perform that function?”

No answers to any of the questions were obtained.

The case was filed in the district clerk’s office at 4 p.m. Friday, Oct. 1, and acknowledged as received by Giffis.

 And, the criminal part of the story may not be over.

 An investigation of Woods’ complaint against Kelehan, based on the series of unusual legal twists and turns of the case, is continuing, according to a state law enforcement official. The official, who requested anonymity due to an “ongoing investigation”, said criminal charges could still be filed in the case, or, based on the events that transpired in this case, it could be taken to a grand jury.”

 The official said, “You have a police investigation, which ended up in charges being filed; you have confessions, on both audio and video; you have a grand jury no-billing a case in which the jurors did not get all the pertinent information, via a decision by the special prosecutor.

“Then,” the official said, “you have a sealed civil suit that no one seems to know about, including the plaintiff’s attorney, and after a question pops up about the case, it’s magically no longer sealed.

“These events could lead to a reopening and expansion of the original case.”


GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE

PO Box 721

Scottsville TX 75688



A Primer on What We Know About Mixing and Matching Covid Vaccines (STAT News):(J. Harris: Readable and meeting ongoing currently.)

”… If you get a booster jab that is of the same brand as your previous jab or jabs, you are getting a homologous booster. In the United States, most people who have been vaccinated have had homologous vaccine series and homologous boosters….If your original series of vaccines or the booster were from different manufacturers, you have what’s called a heterologous vaccine series or a heterologous boost…Kathryn Edwards, a vaccines researcher at Vanderbilt University, suggested the United States should probably look at whether specific brands of booster doses should be targeted at certain populations — or more specifically, if certain people should be steered away from certain vaccines when it comes time for them to get boosters. With concerns about myocarditis in young males associated with mRNA vaccines and clotting problems reported mainly with younger women who got one of the viral vectored vaccines, such as the J&J, maybe it’s time to think about who gets which type of Covid vaccine, Edwards said…A number of countries — the United States among them — do not consider people who received two different brands of vaccines fully vaccinated, even if the person’s home country does. This means someone who got an mRNA vaccine as a second dose after receiving an AstraZeneca shot as a priming dose is not deemed fully vaccinated and is not eligible to travel to the U.S. or other countries with the same rule…the kind of immune response one gets from Covid vaccines is determined by the first dose… “And so it kind of locks you into a repertoire and a pattern of antibody, T-cell balances that carry on through subsequent boosters…Complaints about reactogenicity [discomfort after injection etc] were even greater among people who got mixed vaccine brands, the Com-CoV trial reported…Who then has that responsibility to bring forward a recommendation to mix and match? …”

Tracking the FDA advisory panel meeting on Moderna’s Covid vaccine booster

(J. Harris: FDA vaccine meeting almost live.)

Anchorage approves a mask mandate after two weeks of intense debate.

The order requires everyone to wear a mask or face covering in public indoor spaces, with limited exemptions for younger children and for religious or medical reasons.

An F.D.A. analysis suggests that J.&J. has not presented robust evidence for booster shots.

Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation

(Short, readable school/Covid article.)

Conclusions and Relevance  Despite the implementation of several mitigation measures, the incidence of COVID-19 among children attending primary school in this study was comparable to that observed among teachers and parents. Transmission tree reconstruction suggests that most transmission events originated from within the school. Additional measures should be considered to reduce the transmission of SARS-CoV-2 at school, including intensified testing.



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE



1. MOLNUPIRAVIR EUA REQUEST Merck and Ridgeback Biotherapeutics on October 11 submitted an application with the US FDA for Emergency Use Authorization (EUA) of molnupiravir, an investigation oral antiviral medication, for the treatment of mild-to-moderate COVID-19 in adults at high risk of severe disease. Notably, if authorized by the FDA, the drug would be the first COVID-19 treatment to be administered orally, as all other authorized or approved medications are delivered intravenously or via injection. The companies’ submission is based on a Phase 3 clinical trial interim analysis showing molnupiravir reduced the risk of hospitalization or death by about half when compared with people who received a placebo. The data are not yet published or peer-reviewed. An effective therapeutic that is taken by people recovering at home could relieve some pressure on hospitals, particularly in areas with low vaccination rates. 

Two Indian generic drug manufacturers last week requested permission to end late-stage clinical trials of generic versions of molnupiravir, after the drug did not show “significant efficacy” among people with moderate COVID-19 disease. A Merck spokesperson noted that the Indian studies defined moderate disease differently than the FDA and included patients with more severe disease. The Indian companies are continuing to research the treatment among people with mild COVID-19.

2. ITALY’S GREEN PASS From October 15 through the end of 2021, Italian workers will be required to present a digital or printed “Green Pass” certificate upon entering their workplace, demonstrating that they have recovered from COVID-19 in the last six months, received a negative COVID-19 rapid antigen test result in the last 48 hours, received a negative COVID-19 molecular test result in the last 72 hours, or have been at least partially vaccinated. Workers who do not comply with the new mandate risk fines or suspension. Both civil and violent protests have broken out in response to the September 16 announcement regarding the new mandate in Italy, including reported clashes over the weekend between neo-fascists or other individuals associated with the far right and police. Some employees and policymakers are concerned that a rise in vaccinations may not occur, instead leading to worker shortages due to a lack of available tests. 

The Green Pass already is required in Italy in order to access schools and universities, utilize public transport, participate in gatherings related to civil or religious ceremonies, visit medical facilities or long-term care facilities, access certain public gathering events or spaces, and pass through areas with higher COVID-19 risk—so-called “red” or “orange” zones. The Green Pass also is recognized by the European Union to help travelers avoid COVID-19 travel restrictions. 

Federal vaccine mandates can override Texas’ sweeping new ban, experts say.

”…Courts in the United States have a long history of upholding vaccine mandates,… and of ruling that protecting public health takes precedence over personal choice….The right of the government to impose vaccine mandates has been established at least since 1905, when the Supreme Court ruled that Cambridge, Mass., could require adults there to be vaccinated against smallpox. Later court cases set the legal groundwork for vaccine mandates in schools, health care and other fields…”

(J. Harris:  We Texans don’t like Other Folks telling us what to do, especially not Federal Folks, and mostly, Local Folks don’t like State Folks telling us what to do either. We Texans have had a good long run being our own bosses—EXCEPT where PUBLIC HEALTH is concerned. Even as hardheaded and conservative as I am, I want the Federal Folks to manage and protect the public where certain, mostly communicable diseases, are concerned. States and Counties cannot handle this matter. 

 In addition, Texas’ failure to fully participate in federal Medicaid programs has led to several years of substandard medical care for a significant number of less fortunate and rural Texans and forced the closure or significant modification of many Texas hospitals, emergency rooms, and clinics in rural and small-town Texas. The private, local, personal medical care that most of us grew up with no longer exists, and it is unlikely ever to be resurrected. If you have an accessible physician who knows your name and is competent, you’re fortunate. If you have reasonable access to a “Mission Directed” hospital, you’re fortunate — especially if the hospital has pockets deep enough to survive the occasional pandemic or famine…. But the long-lingering question as to whether good medical care is a right or a privilege is being answered, as it should be.)



GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE


NYT: “… Since January of last year, at least 1 in 7 people who live in the United States have been infected, and at least 1 in 464 people have died…”

Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas

(J. Harris: Short, readable, believable article that is worth the read.)

”…Here, we estimate the deaths, hospital admissions, and infections that could have been averted if Florida and Texas had matched the average vaccination pace of the top-performing states and vaccinated 74·0% of their adult populations by the end of July….By Aug 31, the enhanced vaccination in Florida would have reduced hospital admissions by 61 327 (95% CrI 49 723–73 501) and deaths by 16235 (13 243–19 473)….The reduction in hospital admissions in Texas during the same period would have been 37 587 (95% CrI 31 575–44 659) and the reduction in deaths would have been 6353 (5227–7501). Collectively, these two states could have averted more than 95 000 hospital admissions and 22 000 deaths had they reached the vaccination coverage achieved by the top five states and continued at the same pace until Aug 31, 2021….”

Antithrombotic Therapy for Outpatients With COVID-19

”… currently, the use of aspirin or apixaban for symptomatic but stable ambulatory patients with COVID-19 does not seem justifiable.

(J. Harris: Apixaban is an oral anticoagulant or blood thinner similar to but perhaps better and safer than Coumadin. It is new to me but thought by some to be safer than the older blood thinners.)


New Clues Emerge About Whether Vaccines Can Help Fight Long Covid (Wall Street Journal) Millions of people suffer from symptoms of long Covid, doctors estimate. Now, early research is offering some clues about whether vaccinations might help. When the vaccines first came out, some people who had suffered from debilitating symptoms for months after their initial Covid-19 infections told their doctors they felt better after getting vaccinated. The response intrigued scientists. Now, emerging research suggests that vaccines may help reduce symptoms in some people.

COVID-19: Clinical and Public Health Implications of SARS-CoV-2 Immunology

(J. Harris: Up to date forum and access to previous Annals of Internal Medicine videos.)

”…To address new questions that are emerging about immunity, the duration of protection that follows acute infection and vaccination, and the need for booster doses of vaccine, the most recent forum, held on 8 October 2021, focused on the immunology of SARS-CoV-2 and clinical and public health implications of the virus’s immune behavior…that evidence is currently not sufficient to support antibody measurement in making clinical decisions for individual persons. While many people are seeking antibody tests through a variety of channels and using the results to guide their health decisions, we do not yet know the level of antibody associated with definitive protection……”

Texas Gov. Greg Abbott bans any COVID-19 vaccine mandates — including for private employers

(J. Harris: Do some politicians have trouble sleeping at night? Do they keep up with the body counts? Certain aspects of Public Health require mandates. Period.)


Mary Gold (front center) and some of her new “best friends” now say that they are not sure that they will have enough room in the spring for Milton The Tomato and his wheeling and dealing tomato buddies. Ms Gold said, ” Those inconsiderate tomatoes take up too much space, are frequently sick and wormey, and use up all the water. Maybe they shouldn’t come back? Futhermore,  the Okra! For goodness sakes, the deer come by to nibble on their stalks every night lately. It’s hard to get any rest.”


GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

Click here to submit feedback.  Let us know what you think.

click here to CLOSE THIS PAGE